Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.32 |
| ▸ | FDPS | P14324 | 3/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3427139 | 0.93 | — | — | |
| SCHEMBL2800515 | 0.85 | — | — | |
| SCHEMBL1131040 | 0.85 | TSHR (0.48) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL3474884 | 0.84 | TSHR (0.39) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL24044418 | 0.82 | TSHR (0.46) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL13601912 | 0.82 | TSHR (0.46) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL4745188 | 0.82 | TSHR (0.46) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL366647 | 0.82 | TSHR (0.46) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL15211724 | 0.82 | TSHR (0.46) | TSHROPRM1LMNADNM1FDPS | |
| SCHEMBL10155552 | 0.82 | TSHR (0.46) | TSHROPRM1LMNADNM1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2274286-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING SAID COMPOUNDS, AND USE THEREOF | The Procter & Gamble Company (US) | 2011-01-19 | — | — | EP | claimed |
| WO-2009140451-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING SAID COMPOUNDS, AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2009-11-19 | — | — | WO | claimed |
| US-7790897-B2 | Graftable hindered amine light stabilizers | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090144915-A1 | Graftable hindered amine light stabilizers | MEIER HANS-RUDOLF | 2009-06-11 | — | — | US | disclosed |
| US-7504510-B2 | Graftable hindered amine light stabilizers | CIBA SPECIALTY CHEMICALS CORP. (US) | 2009-03-17 | — | — | US | disclosed |
| EP-1592664-B1 | GRAFTABLE HINDERED AMINE LIGHT STABILIZERS | CIBA SC HOLDING AG (CH) | 2006-08-23 | — | — | EP | disclosed |
| US-20060173107-A1 | Graftable hindered amine light stabilizers | CIBA SPECIALTY CHEMICALS CORP. | 2006-08-03 | — | — | US | disclosed |
| EP-1592664-A1 | GRAFTABLE HINDERED AMINE LIGHT STABILIZERS | Ciba SC Holding AG (CH) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004072035-A1 | GRAFTABLE HINDERED AMINE LIGHT STABILIZERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090144915-A1 | Graftable hindered amine light stabilizers | IDO1, MAOA, AOX1 | TSHR 3638/4885OPRM1 603/4885LMNA 3452/4885 |
| US-20060173107-A1 | Graftable hindered amine light stabilizers | IDO1, MAOA, TPH1 | TSHR 3853/4885OPRM1 699/4885LMNA 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.